Literature DB >> 13840330

Prevalence of poliomyelitis neutralizing antibodies in Norwegian school children before vaccination.

J C ULSTRUP, R MEMMER.   

Abstract

Entities:  

Keywords:  POLIOMYELITIS/immunology

Mesh:

Substances:

Year:  1959        PMID: 13840330     DOI: 10.1007/bf01248827

Source DB:  PubMed          Journal:  Arch Gesamte Virusforsch        ISSN: 0003-9012


× No keyword cloud information.
  8 in total

1.  Propagation in vitro of poliomyelitis viruses. VII. pH change of HeLa cell cultures for assay.

Authors:  H E ROBERTSON; K T BRUNNER; J T SYVERTON
Journal:  Proc Soc Exp Biol Med       Date:  1955-01

2.  A simplified colorimetric test for poliomyelitis virus and antibody.

Authors:  M M LIPTON; A J STEIGMAN
Journal:  Proc Soc Exp Biol Med       Date:  1955-01

3.  Antibody response to Salk vaccine in Norwegian school children.

Authors:  J C ULSTRUP; R MEMMER
Journal:  Arch Gesamte Virusforsch       Date:  1959

4.  Factors influencing the potency of poliomyelitis complement-fixing antigens produced in tissue-culture systems.

Authors:  N J SCHMIDT; E H LENNETTE; J H DOLEMAN; S J HAGENS
Journal:  Am J Hyg       Date:  1957-07

5.  Requirements for persistent immunity to poliomyelitis.

Authors:  J E SALK
Journal:  Am J Med Sci       Date:  1956-10       Impact factor: 2.378

6.  Assay of poliomyelitis neutralizing antibody in disposable plastic panels.

Authors:  J L MELNICK; E M OPTON
Journal:  Bull World Health Organ       Date:  1956       Impact factor: 9.408

7.  Seroimmune patterns for poliomyelitis in Sweden.

Authors:  G OLIN; T WESSLEN
Journal:  Arch Gesamte Virusforsch       Date:  1957

8.  Transitory appearance of type 2 neutralizing antibody in patients infected with type 1 poliomyelitis virus.

Authors:  A B SABIN
Journal:  J Exp Med       Date:  1952-07       Impact factor: 14.307

  8 in total
  1 in total

1.  Antibody response to Salk vaccine in Norwegian school children.

Authors:  J C ULSTRUP; R MEMMER
Journal:  Arch Gesamte Virusforsch       Date:  1959
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.